William Arsani - Insider Non-Derivative Transactions at Design Therapeutics, Inc. (DSGN) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Aug 13, 2025, William Arsani's relationship to Design Therapeutics, Inc. (DSGN) is Director, and currently has 2,655,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other DSGN insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

William Arsani - Insider Non-Derivative Transactions of DSGN Common Stock

William Arsani - Insider Non-Derivative Transactions at DSGN

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Aug 14, 2025	Sell -- (Common Stock)	217627	5.25	1000000
Aug 14, 2025	Sell -- (Common Stock)	345000	5.25	2655000
Aug 10, 2024	Sell -- (Common Stock)	814874	4.25	0
Aug 30, 2023	P -- (Common Stock)	1960000	2.44	3000000
Aug 29, 2023	P -- (Common Stock)	275000	2.15	1040000
Mar 31, 2021	P -- (Common Stock)	700000	20	700000
Mar 31, 2021	C -- (Common Stock)	814874	0	814874
Mar 31, 2021	C -- (Common Stock)	1217627	0	1217627